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Pathogenic Inflammation in Fungal Infections:
the Contribution of the Th17 Pathway
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Francesca Fallarino, Paolo Puccetti, Luigina Romani. Department
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Background: The inflammatory response to fungi may serve to
limit infection but an overzealous or heightened inflammatory re-
sponse may contribute to pathogenicity, as documented by the
occurrence of intractable fungal infections in patients with im-
munoreconstitution disease or primary immunodeficiencies asso-
ciated with heightened immune reactivity. IL-12, by initiating and
maintaining Th1 responses, was thought to be responsible for over-
reacting immune and autoimmune disorders. The newly described
Th17 pathway is now thought to contribute to immune pathogene-
sis previously attributed to the Th1 lineage.
Objective: This study examined the role of Th17 in inflammation
and immunity to Candida albicans or Aspergillus fumigatus in ex-
perimental models of infections.
Methods: Mice with selected genetic deficiencies (i.e, IL-23, IL-12
or both or TLR-deficient) were exposed to C. albicans or A. fu-
migatus and assessed for susceptibility to infection, gut or airway
inflammation, and parameters of innate and adaptive immunity.
Results: The Th17 pathway – and not the uncontrolled Th1 re-
sponse – was associated with defective pathogen clearance, failure
to resolve inflammation and initiate protective immune responses.
Conditions of high-threat inflammation predisposed to Th17 acti-
vation, whereby the unrestricted fungal growth resulted from the
activation of not only pathogenic Th17 cells but also Th2 cells,
whose activation is strictly dependent on fungal burden. Block-
ade of IL-17/IL-23 prevented pathogenic inflammatory responses,
ameliorated infections and restored protective Th1 antifungal re-
sistance, thus causally linking pathogenic inflammation to Th17 de-
velopment.
Conclusion and clinical implications: The above findings provide a
molecular connection between the failure to resolve inflammation
and lack of antifungal immune resistance and point to strategies
for immune therapy of fungal infections that attempt to limit in-
flammation to stimulate an effective immune response. Inhibition
of the Th17 pathway may potentially represent a novel strategy
for the prevention of inflammatory immunity and allergy in fungal
diseases.
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Background: Aspergillus fumigatus is the most commonly identi-
fied cause of invasive aspergillosis in immunocompromised hosts
with significant attributable mortality and morbidity. To date, not
much is known about the pathophysiology and host response to
such mould infections
Objective: We aimed to study how A. fumigatus may modulate the
host innate immune system to its own advantage in the course of
invasive disease.
Methods: Peripheral blood mononuclear cells (PBMCs), isolated
from venous blood of healthy volunteers by density centrifugation
on Ficoll-Hypaque, were preincubated with A. fumigatus conidia
(107cfu/ml) as a priming stimulus in RPMI for 24h, after which
cells were exposed to a secondary stimulus to detect the respec-
tive immunomodulatory effects. As secondary stimulus, TLR2 lig-
and Pam3Cys 10ug/ml or TLR4 ligand E. coli lipopolysaccharide
1ng/ml was used. Cytokine production (IL-6, TNF, IL-1b) was mea-
sured by ELISA. Quantitative PCR was performed for TLR2, TLR4
mRNA (24h after priming of PBMCs with Aspergillus); IL-1b and TNF
mRNA (4h after secondary stimuli). Mean relative mRNA expression
was measured. To analyse the involvement of phagocytic activity
and dectin-1 receptor, cytochalasin B and laminarin were added re-
spectively. Results were pooled from at least 3 sets of experiments.
Statistical significance was set at 0.05 (Wilcoxon Signed Rank).
Results: PBMCs primed with A. fumigatus conidia produced signifi-
cantly less IL-6 and IL-1b in response to subsequent TLR2 and TLR4
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Figure 1a. Asp conidia attenuates IL6 response in presence of TLR2/TLR4
ligands. Attenuated response only with TLR4 ligand in Asp hyphae.
Figure 1b. TNF production not attenuated by Asp conidia in contrast to IL6.
Decreased TNF response with TLR4 ligand in Asp hyphae.
ligand stimulation. TNF production remained unchanged (Figures
1a & b).
The observed TLR-2 modulation involved phagocytosis, as addition
of cytochalasin B reversed the observed attenuation, while no in-
fluence was seen by signalling through TLR4. This effect was not
mediated by dectin-1 receptor. IL-1b mRNA expression decreased
in response to Aspergillus conidia. TNF, TLR2 and TLR4 mRNA ex-
pression was not significantly attenuated after exposure to As-
pergillus.
Conclusions: We elicited a novel phenomenon by which A. fumi-
gatus attenuates host immune response via distinct means. Mono-
cytic phagocytosis of A. fumigatus conidia results in an attenuated
proinflammatory IL-1b and IL-6 response via TLR2 likely secondary
to depletion of surface TLR2. TLR4 modulation by conidia though,
affects transcription processes upstream independent of phagocy-
tosis. Induction of proinflammatory cytokines TNF and IL-1b/IL-6
by A. fumigatus purportedly involved distinct pathways.
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TLR4 Receptor Polymorphisms are Associated with
Gram-negative Bacteremia after Allogeneic Stem Cell
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Background: Bloodstream infection (BSI) by Gram-negative organ-
isms (GNR) occurs in approximately 20% of allogenic hemopoi-
etic stem cell transplant recipients (HSCT). Toll-like receptor
4 (TLR4), has been shown to be a major recognition receptor
for Gram-negative pathogens and specifically lipopolysaccharide
(LPS). The missense mutations TLR4Asp299Gly and co-segregating
TLR4 Thr399Ile are found in approximately 6-10% of Caucasians.
Heterozygosity for TLR4 Asp299Gly TLR4 is associated with hypo-
responsiveness to LPS. We followed prospectively a cohort of 105
allogeneic HSCT to study the association of TLR4Asp299Gly and
Thr399Ile in the donor or recipient with mutations with GNR BSI
after HSCT.
Methods: The study was approved by the MSKCC Institutional Re-
view Board. Patients were followed up to onset of BSI, death or
end of study, whichever occurred first. DNA for donor and recipient
was extracted from whole blood. TLR4 genotyping was performed
by direct sequencing. Genotypes were tabulated as presence or ab-
sence of the minor allele at each locus, separately for the donors
and recipients. “Risk genotype” was defined as heterozygous at
TLR4 299AspGly and Thr399Ile. The cumulative incidence of infec-
tion was estimated by treating death prior to the onset of infection
as a competing risk event, and compared between relevant groups
using a modified chi-squared test.
Results: Ten of 95 (10.5%) donors and 8/88 (9.1%) recipients had
the risk genotype. Twenty-one out of 105 (20%) patients developed
BSI at 1-381 days post transplant. Twenty-seven percent (27%) of
patients with BSI had donor risk genotype compared to 6.4% of pa-
tients without BSI (p=0.01). In contrast, examination of recipient
genotypes showed similar frequencies of “risk genotype” among
patients with or without BSI (5.5% versus 8.5%, p-value = 0.59) (Ta-
ble 1). The cumulative incidence of infection was higher for pa-
tients with donor with risk genotype to patients without risk geno-
type. In contrast, when recipient genotypes were examined the
cumulative incidence of BSI was similar between the two groups
(Figure 1).
Table 1
TLR4 Genotype GNR BSI P-value
Yes No
N (%) N (%)
Donor Risk genotype 5 (27.7) 5 (6.4)
No risk genotype 13 (72.3) 72 (93.6) 0.01
Total 18 (100) 77 (100)
Recipient Risk genotype 17 (94.5) 64 (91.5) 0.59
No risk genotype 1 ( 5.5) 6 (8.5)
Total 18 (100) 70 (100)
Figure 1. Cumulative incidence of Gram-negative BSI or mortality without
BSI by donor type.
Conclusions: This is the first prospective study suggesting an as-
sociation of TLR4 polymorphisms with Gram-negative bloodstream
infection after allogeneic HSCT. The ability to predict genetic sus-
ceptibility to a common infection with substantial morbidity is of
direct relevance to the design of strategies to protect most vulner-
able patients.
